ABOUT US
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
PRODUCTS
NGS Assays Real-time PCR Assays FISH Assays Extraction
GLOBAL BUSINESS
Distributorship
SUPPORT
Customer Service
FAQs
DOWNLOAD
MEET US
MEET US
language
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
Log in
Log in
Search
HRD Focus 2019-nCoV NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
ABOUT US PRODUCTS GLOBAL BUSINESS SUPPORT MEET US
Search
Search
Search results 6
All (6)
News & Events (3)
PRODUCTS (1)
DOWNLOAD (2)
AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit approved by Chinese Authority
AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit was approved by Chinese National Medical Products Administration (NMPA) on February 27, 2019, intended for qualitative detection of gene BRCA1 and BRCA2 mutation in patients with different cancer types  
News & Events
AmoyDx® Essential NGS panel approval from Chinese authority
AmoyDx® Essential NGS panel was approved by Chinese National Medical Products Administration (NMPA) on November 20, 2018, for qualitative detection of gene mutations in patients with Non-Small Cell
News & Events
Visit AmoyDx at the 19th World Conference on Lung Cancer (WCLC) 2018 in Canada
Amoy Diagnostics will be exhibiting at 19th World Conference on Lung Cancer 2018 of IASLC in Toronto, Canada. Welcome to visit us at booth 206.
News & Events
Essential NGS Panel
Focus on 10 driver genes for clinical targeted therapy.
PRODUCTS
AmoyDx® Essential NGS Panel-B1.0-24T-CE
DOWNLOAD
AmoyDx® Essential NGS Panel-B2.0-24T-RUO
DOWNLOAD
no more...
AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit approved by Chinese Authority
AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit was approved by Chinese National Medical Products Administration (NMPA) on February 27, 2019, intended for qualitative detection of gene BRCA1 and BRCA2 mutation in patients with different cancer types  
News & Events
AmoyDx® Essential NGS panel approval from Chinese authority
AmoyDx® Essential NGS panel was approved by Chinese National Medical Products Administration (NMPA) on November 20, 2018, for qualitative detection of gene mutations in patients with Non-Small Cell
News & Events
Visit AmoyDx at the 19th World Conference on Lung Cancer (WCLC) 2018 in Canada
Amoy Diagnostics will be exhibiting at 19th World Conference on Lung Cancer 2018 of IASLC in Toronto, Canada. Welcome to visit us at booth 206.
News & Events
no more...
Essential NGS Panel
Focus on 10 driver genes for clinical targeted therapy.
PRODUCTS
no more...
AmoyDx® Essential NGS Panel-B1.0-24T-CE
DOWNLOAD
AmoyDx® Essential NGS Panel-B2.0-24T-RUO
DOWNLOAD
no more...
no more...
Inquiry
* Required information
Refresh the image
send
Manage your account info
  • Please Select
  • Mr.
  • Ms.
  • Dr.
  • Prof.
Submit
Change your password
Confirm Submission